bibliographicCitation |
Zhao J, Dong QZ, Zhong F, Cai LL, Qin ZY, Liu Y, Lin CZ, Qin LX, He FC. NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway. Oncotarget. 2017 Feb 14;8(7):12174–85. PMID: 28077802; PMCID: PMC5355334. |